GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Gross Profit

Novartis India (BOM:500672) Gross Profit : ₹1,352 Mil (TTM As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India Gross Profit?

Novartis India's gross profit for the three months ended in Mar. 2024 was ₹243 Mil. Novartis India's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,352 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Novartis India's gross profit for the three months ended in Mar. 2024 was ₹243 Mil. Novartis India's Revenue for the three months ended in Mar. 2024 was ₹812 Mil. Therefore, Novartis India's Gross Margin % for the quarter that ended in Mar. 2024 was 29.91%.

Novartis India had a gross margin of 29.91% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Novartis India was 59.07%. The lowest was 40.36%. And the median was 54.06%.

Warning Sign:

Novartis India Ltd gross margin has been in long-term decline. The average rate of decline per year is -6%.


Novartis India Gross Profit Historical Data

The historical data trend for Novartis India's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Gross Profit Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,259.90 2,159.80 2,060.90 1,770.50 1,352.30

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.70 378.60 340.40 390.50 242.80

Competitive Comparison of Novartis India's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's Gross Profit distribution charts can be found below:

* The bar in red indicates where Novartis India's Gross Profit falls into.



Novartis India Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Novartis India's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=3350.7 - 1998.4
=1,352

Novartis India's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=811.7 - 568.9
=243

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,352 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Novartis India's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=243 / 811.7
=29.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Novartis India  (BOM:500672) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Novartis India had a gross margin of 29.91% for the quarter that ended in Mar. 2024 => Competition eroding margins


Novartis India Gross Profit Related Terms

Thank you for viewing the detailed overview of Novartis India's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines